Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.

1st Department of Obstetrics and Gynecology, Faculty of Medicine, Comenius University, Zochova 7, 811 03 Bratislava, Slovak Republic.
Mycopathologia (Impact Factor: 1.55). 03/2004; 157(2):163-9. DOI: 10.1023/B:MYCO.0000020594.35357.b0
Source: PubMed

ABSTRACT Vulvovaginal candidiasis is a common mucosal infection caused by opportunistic yeasts of the Candida genus. In this study, we isolated and identified the yeast species in the vagina of patients treated in the gynecology clinic and tested in vitro activities of fluconazole and itraconazole against 227 clinical yeast isolates by the NCCLS microdilution method. C. albicans (87.6%) was the most frequently identified species followed by C. glabrata (6.2%) and C. krusei (2.2%). Almost thirteen percent of yeast strains were resistant to fluconazole and 18.5% were resistant to itraconazole. Cross-resistance analyses of C. albicans isolates revealed that fluconazole resistance and itraconazole resistance were also associated with decreased susceptibilities to other azole derivatives mainly to ketoconazole and miconazole. At the same time no cross-resistance to polyene antibiotics amphotericin B and nystatin was observed. These results support the notion that antifungal agents used to treat vaginitis may be contributing to the drug resistance problem by promoting cross-resistance to a range of clinically used antifungals.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of novel molecules 5a-g containing N-aryl maleimide and α-hydroxyphosphonate moieties were synthesized. A distinct approach for high-yielding synthesis of α-hydroxyphosphonates has been discovered using various catalyst and solvents. The structures of the synthesized compounds were elucidated by IR, NMR, MS and CHN analysis. All the synthesized compounds were tested for qualitative (Zone of inhibition) and quantitative (MIC) antimicrobial activities against two pathogenic bacteria such as Bacillus subtilis (NCIM 2250) and Escherichia coli (ATCC 25922) and four pathogenic fungi such as Candida albicans (MTCC 277), Candida tropicalis (MTCC184), Aspergillus niger (MCIM 545) and Aspergillus clavatus (MTCC 132). The investigation of antimicrobial screening data revealed that most of the tested compounds are moderate to good microbial inhibitors.
    European Journal of Medicinal Chemistry 06/2014; 83C:490-497. · 3.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: This is the first multi centre study regarding yeast infections in Romania. The aim was to determine the aetiological spectrum and the susceptibility pattern to fluconazole, voriconazole and the novel compound MXP 4509. Methods: The 551 isolates were identified using routine laboratory methods, MALDI TOF MS and DNA sequence analysis. Susceptibility testing was performed using the EUCAST method and breakpoints. Results: The yeasts originated from superficial infections–SUP (51.5%), bloodstream infections–BSI (31.6%) and deep seated infections–DEEP (16.9%), from patients of all ages. Nine genera and 30 species were identified. The 20 Candida species accounted for 94.6% of all isolates. C. albicans was the overall leading pathogen (50.5%). Lodderomyces elongisporus is reported for the first time as a fungemia cause in Europe. C. glabrata and S. cerevisiae as well as the non Candida spp. and non albicans Candida spp. groups showed decreased fluconazole susceptibility (<75%). Overall fluconazole resistance was 10.2%. C. krusei accounted for 27 of the 56 fluconazole resistant isolates. Overall voriconazole resistance was 2.5% and was due mainly to C. glabrata and C. tropicalis isolates. Fluconazole resistance rates for the three categories of infection were similar to the overall value; voriconazole resistance rates differed: 4% for BSI, 3.2% for DEEP and 1.4% for SUP. The antifungal activity of MXP 4509 was superior to voriconazole against C. glabrata and many fluconazole resistant isolates. Conclusions: There was a large percent of non albicans Candida isolates. A large part of the high fluconazole resistance was not acquired but intrinsic, resulting from the high percentage of C. krusei.
    European Journal of Clinical Microbiology 08/2014; · 3.02 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study we planned to investigate the differences of the Candida species in the newborns' and adults' mouth flora, their slime production and antimicrobial susceptibility. They were identified with conventional methods (germ tube production) and carbohydrate fermentation characteristics were evaluated by Api 20 C AUX (bioMerieux-France) kits. Stock solution of fluconazole was used for antibiotic susceptibility test. A total of 18 Candida isolates; 14 C. albicans, 2 C. tropicalis, 1 C. kefyr and1 C. lusitaneae were isolated from newborns and 18 Candida strains consisting of 13 C. albicans, 4 C. tropicalis and 1 C. ciferii were isolated from the adults with decayed teeth. Slime production and fluconazole susceptibility tests were performed on these strains. As a result, 4 of 18 (22%) Candida species from newborns and 2 of 18 (11%) strains from adults teeth were observed to be potent slime producer. None of the Candida strains isolated were resistant to fluconazole.


Available from
May 17, 2014